open access

Vol 5, No 3 (2019)
Prace poglądowe
Published online: 2019-09-19
Get Citation

Erectile dysfunctions in patients with systemic sclerosis

Monika Chrzanowska, Eugeniusz Józef Kucharz
DOI: 10.5603/FR.2019.0013
·
Forum Reumatologiczne 2019;5(3):118-123.

open access

Vol 5, No 3 (2019)
Prace poglądowe
Published online: 2019-09-19

Abstract

Erectile dysfunctions are a common feature in patients with systemic sclerosis. They are resulted from a complex pathomechanism. The main role is attributed to vascular alterations and fibrosis of the carvernous bodies. Depression and disturbed autonomy nervous system function may be additional factors for development of erectile dysfunctions. Diagnosis is based on subjective patient’s data and functional tests. Treatment of erectile dysfunctions in scleroderma patients is difficult, multifactorial and sometimes ineffective.

Forum Reumatol. 2019, tom 5, nr 3: 118–123

Abstract

Erectile dysfunctions are a common feature in patients with systemic sclerosis. They are resulted from a complex pathomechanism. The main role is attributed to vascular alterations and fibrosis of the carvernous bodies. Depression and disturbed autonomy nervous system function may be additional factors for development of erectile dysfunctions. Diagnosis is based on subjective patient’s data and functional tests. Treatment of erectile dysfunctions in scleroderma patients is difficult, multifactorial and sometimes ineffective.

Forum Reumatol. 2019, tom 5, nr 3: 118–123

Get Citation

Keywords

systemic sclerosis; erectile dysfunctions; impotence

About this article
Title

Erectile dysfunctions in patients with systemic sclerosis

Journal

Forum Reumatologiczne

Issue

Vol 5, No 3 (2019)

Pages

118-123

Published online

2019-09-19

DOI

10.5603/FR.2019.0013

Bibliographic record

Forum Reumatologiczne 2019;5(3):118-123.

Keywords

systemic sclerosis
erectile dysfunctions
impotence

Authors

Monika Chrzanowska
Eugeniusz Józef Kucharz

References (38)
  1. Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017; 390(10103): 1685–1699.
  2. Kowal-Bielecka O, Bielecki M. Twardzina układowa. In: Puszczewicz M. ed. Wielka Interna. Reumatologia, wyd. II. Medical Tribune, Warszawa 2016: 136–150.
  3. Kucharz EJ. Reumatoseksuologia: wprowadzenie do problematyki interdyscyplinarnej. Reumatologia. 2010; 48: 155–158.
  4. Bruni C, Raja J, Denton CP, et al. The clinical relevance of sexual dysfunction in systemic sclerosis. Autoimmun Rev. 2015; 14(12): 1111–1115.
  5. Grant P, Jackson G, Baig I, et al. Erectile dysfunction in general medicine. Clin Med (Lond). 2013; 13(2): 136–140.
  6. Lally EV, Burnett AL, Bivalacqua TJ. Erectile dysfunctions. In: Varga J, Denton CP, Wigley FM. ed. Scleroderma: from pathogenesis to comprehensive management. Springer, New York 2012: 395–398.
  7. Bivalacqua TJ, Usta MF, Champion HC, et al. Endothelial dysfunction in erectile dysfunction: role of the endothelin in scleroderma and rheumatoid arthritis. J Rheumatol. 2004; 31: 508–513.
  8. Nehra A, Hall SJ, Basile G, et al. Systemic sclerosis and impotence: a clinicopathological correlation. J Urol. 1995; 153(4): 1140–1146.
  9. Manetti M, Romano E, Rosa I, et al. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis. Ann Rheum Dis. 2017; 76(5): 924–934.
  10. Dessein PH, Joffe BI, Metz RM, et al. Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability. Am J Med. 1992; 93(2): 143–150.
  11. Straszecka J, Kucharz EJ, Jonderko G, et al. Depression and anxiety in patients with systemic sclerosis. Clin Rheumatol. 1996; 15(6): 621.
  12. Ostojic P, Damjanov N. The impact of depression, microvasculopathy, and fibrosis on development of erectile dysfunction in men with systemic sclerosis. Clin Rheumatol. 2007; 26(10): 1671–1674.
  13. Lewis RW, Fugl-Meyer KS, Corona G, et al. Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med. 2010; 7(4 Pt 2): 1598–1607.
  14. Jaeger VK, Walker UA. Erectile Dysfunction in Systemic Sclerosis. Curr Rheumatol Rep. 2016; 18(8): 49.
  15. Inman BA, Sauver JL, Jacobson DJ, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc. 2009; 84(2): 108–113.
  16. Thompson IM, Tangen CM, Goodman PJ, et al. Erectile dysfunction and subsequent cardiovascular disease. JAMA. 2005; 294(23): 2996–3002.
  17. Sedky Abdou MM, El Desouky SM, Helmy El Kaffas KM, et al. Premature atherosclerosis in systemic sclerosis patients: Its relation to disease parameters and to traditional risk factors. Int J Rheum Dis. 2017; 20(3): 383–389.
  18. Lally EV, Jimenez SA. Impotence in progressively systemic sclerosis. Ann Intern Med. 1981; 95(2): 150–153.
  19. Nowlin NS, Brick JE, Weaver DJ, et al. Impotence in scleroderma. Ann Intern Med. 1986; 104(6): 794–798.
  20. Hong P, Pope JE, Ouimet JM, et al. Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis. J Rheumatol. 2004; 31(3): 508–513.
  21. Fransen J, Inanc M. Epidemiology. In: Hachulla E, Czirják L. ed. EULAR Textbook on systemic sclerosis. BMJ, London 2013: 28–37.
  22. Foocharoen C, Tyndall A, Hachulla E, et al. Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group. Arthritis Res Ther. 2012; 14(1): R37.
  23. Ponholzer A, Temml C, Mock K, et al. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol. 2005; 47(1): 80–5; discussion 85.
  24. Horimoto AM, da Costa IP. Overlap between systemic sclerosis and rheumatoid arthritis: a distinct clinical entity? Rev Bras Reumatol Engl Ed. 2016; 56(4): 287–298.
  25. Rosato E, Barbano B, Gigante A, et al. Doppler ultrasound study of penis in men with systemic sclerosis: a correlation with Doppler indices of renal and digital arteries. Int J Immunopathol Pharmacol. 2013; 26(4): 1007–1011.
  26. Aversa A, Proietti M, Bruzziches R, et al. The penile vasculature in systemic sclerosis: A duplex ultrasound study. J Sex Med. 2006; 3(3): 554–558.
  27. Rosato E, Aversa A, Molinaro I, et al. Erectile dysfunction of sclerodermic patients correlates with digital vascular damage. Eur J Intern Med. 2011; 22(3): 318–321.
  28. Keck AD, Foocharoen C, Rosato E, et al. Nailfold capillary abnormalities in erectile dysfunction of systemic sclerosis: a EUSTAR group analysis. Rheumatology (Oxford). 2014; 53(4): 639–643.
  29. Aversa A, Bruzziches R, Francomano D, et al. Penile involvement in Systemic Sclerosis: New Diagnostic and Therapeutic Aspects. Int J Rheumatol. 2010; 2010: 708067.
  30. Merla A, Romani GL, Tangherlini A, et al. Penile cutaneous temperature in systemic sclerosis: a thermal imaging study. Int J Immunopathol Pharmacol. 2007; 20(1): 139–144.
  31. Gigante A, Navarini L, Margiotta D, et al. Erectile dysfunction: Imbalance between pro-angiogenic and anti-angiogenic factors in systemic sclerosis. Eur J Intern Med. 2018; 53: e17–e18.
  32. Kucharz EJ, Kotulska A. Patofizjologiczna rola endostatyny w chorobach nienowotworowych. Pol Arch Med Wewn. 2006; 11: 507–511.
  33. Kucharz EJ, Jarczyk R, Jonderko G, et al. High serum level of prolactin in patients with systemic sclerosis. Clin Rheumatol. 1996; 15(3): 314.
  34. Kucharz EJ. Thyroid disorders in patients with progressive systemic sclerosis: a review. Clin Rheumatol. 1993; 12(2): 159–161.
  35. Sanchez K, Denys P, Giuliano F, et al. Systemic sclerosis: Sexual dysfunction and lower urinary tract symptoms in 73 patients. Presse Med. 2016; 45(4 Pt 1): e79–e89.
  36. Proietti M, Aversa A, Letizia C, et al. Erectile dysfunction in systemic sclerosis: effects of longterm inhibition of phosphodiesterase type-5 on erectile function and plasma endothelin-1 levels. J Rheumatol. 2007; 34(8): 1712–1717.
  37. Hanchanale V, Eardley I. Alprostadil for the treatment of impotence. Expert Opin Pharmacother. 2014; 15(3): 421–428.
  38. Condorelli RA, Calogero AE, Vicari E, et al. Vascular regenerative therapies for the treatment of erectile dysfunction: current approaches. Andrology. 2013; 1(4): 533–540.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl